QuadraMed’s Top-Ranked EHR and Identity Management Solutions Featured at HIMSS10 Interoperability Showcase

QuadraMed® Corporation (NASDAQ:QDHC), a leading provider of healthcare technologies and services that help turn quality care into positive financial outcomes, will demonstrate its award-winning electronic health record (EHR) and Smart Identity Management solutions at the annual Healthcare Information and Management Systems Society (HIMSS) Conference and Exhibition’s Interoperability Showcase. The event takes place March 1-4 at the Georgia World Congress Center in Atlanta.

The HIMSS Interoperability Showcase, located at booth #233 in Hall C, will incorporate the initial, proposed metrics of “Meaningful Use” of electronic health record and other connected systems as part of its real-time demonstrations. QCPR, QuadraMed’s comprehensive EHR solution, will enable attendees to experience how patient information from two unique ambulatory scenarios can be retrieved and displayed from a centralized document repository and accessed by primary care physicians and other care providers.

QuadraMed’s “Best in KLAS,” Smart Identity Management solutions will enable attendees to experience how healthcare providers can locate, accurately identify and cross reference their unique EHR through complex healthcare scenarios utilizing the standards-based Integrating the Healthcare Enterprise (IHE) framework.

“Our clients count on QuadraMed as a trusted technology partner that will help them meet today’s evolving healthcare challenges and improve code quality and efficiency,” said Duncan W. James, president and CEO of QuadraMed. “As hospitals and physicians move toward greater use of EHR technology and solutions to assist with upcoming challenges, such as the transition to ICD-10, we’re proud to demonstrate how our acclaimed QCPR solution can positively impact quality of care, while helping hospitals meet “meaningful use” criteria and qualify for ARRA stimulus funds.”

In addition to QuadraMed’s EHR and Smart Identity Management solutions, QuadraMed will also be demonstrating its new ICD-10 Countdown and Computer-Assisted Coding solutions in exhibit booth #6433.

With QuadraMed's ICD-10 Countdown Program, hospitals can actively plan and prepare for the transition ICD-10. By taking advantage of this unique program consisting of the ICD-10 Simulator software and educational services, coders can gain hands-on expertise in ICD-10 now ─ to help avoid business disruptions later.

Attendees are invited to meet Glen Mamary, chief information officer of Flemington, New Jersey’s Hunterdon Medical Center at QuadraMed’s booth #6433. Mamary’s organization received the 2009 QUEST integration achievement award from QuadraMed for linking its Affinity Order Management system and an external laboratory to QuadraMed’s award winning EHR solution. Glenn will join QuadraMed product management during an in-booth session focused on how QCPR helps clients meet “meaningful use” criteria, and share his first-hand experience using QuadraMed’s solutions.

For more information about any of QuadraMed’s in-booth presentations at HIMSS 2010, or to register for QCPR and Meaningful Use Criteria, visit http://www.quadramed.com/himss10/.

About QuadraMed Corporation

QuadraMed® (NASDAQ:QDHC) is a leading provider of healthcare technologies and services that help turn quality care into positive financial outcomes. QuadraMed provides innovative solutions that streamline processes, ensure compliance and help healthcare professionals deliver quality patient care. Behind the Company's products and services is a staff of 600 professionals whose experience and dedication have earned QuadraMed the trust and loyalty of clients at over 2,000 healthcare provider facilities. For more information about QuadraMed, visit http://www.quadramed.com

Cautionary Statement on Risks Associated with QuadraMed Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. The words “believe,” “expect,” “target,” “goal,” “project,” “anticipate,” “predict,” “intend,” “plan,” “estimate,” “may,” “will,” “should,” “could” and similar expressions and their negatives are intended to identify such statements. Forward-looking statements are not guarantees of future performance, anticipated trends or growth in businesses, or other characterizations of future events or circumstances and are to be interpreted only as of the date on which they are made. QuadraMed undertakes no obligation to update or revise any forward-looking statement. You should not place undue reliance on these forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including the risks faced by QuadraMed described in documents filed with the Securities and Exchange Commission ("SEC") from time to time. QuadraMed’s SEC filings can be accessed through the Investor Relations section of our website, www.quadramed.com, or through the SEC’s EDGAR Database at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833).

QuadraMed is a registered trademark of QuadraMed Corporation. All other trademarks are the property of their respective holders.